Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guimu Guo

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Expert Opinion on Drug Safety|January 21, 2026
Dipyridamole-associated pulmonary edema: discovery of a new potential adverse reaction signal based on the FAERS databaseXiaomin Dong, Guimu Guo, Jintuo Zhou, et al.
Journal of Pharmaceutical Sciences|October 27, 2021
Development of Physiologically Based Pharmacokinetic Model for Pregabalin to Predict the Pharmacokinetics in Pediatric Patients with Renal Impairment and Adjust Dosage Regimens: PBPK Model of Pregabalin in Pediatric Patients with Renal ImpairmentChengjie Ke, Xiang You, Cuihong Lin, et al.
Journal of Endocrinological Investigation|May 6, 2026
Mining safety signals of PD-1/PD-L1 inhibitor-related adrenal insufficiency: a study based on the FAERS databaseRuoxuan Pan, Tingting Chen, Guimu Guo, et al.
Clinical Pharmacology and Therapeutics|August 24, 2023
Physiologically-Based Pharmacokinetic Modeling of Anti-Tumor Necrosis Factor Agents for Inflammatory Bowel Disease Patients to Predict the Withdrawal Time in Pregnancy and Vaccine Time in InfantsJiarui Chen, Rongfang Lin, Guimu Guo, et al.
Pharmaceutics|November 11, 2022
Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to OxcarbazepineLixia He, Meng Ke, Wanhong Wu, et al.
Journal of Pharmaceutical Sciences|November 3, 2025
Pharmacokinetic prediction and dosage adjustment of enoxaparin administration in pregnant women with renal insufficiency: A FAERS-PBPK modeling studyGuimu Guo, Lingling Ye, Tingting Chen, et al.
Frontiers in Pharmacology|April 15, 2025
Physiologically based pharmacokinetic model of sodium-glucose cotransporter 2 inhibitors predicted pharmacokinetics and pharmacodynamics to explore dosage regimen for patients with type 2 diabetes mellitus and renal insufficiencyGuimu Guo, Meng Ke, Jianwen Xu, et al.
Journal of Clinical Pharmacology|July 30, 2021
Ceftaroline Dosage Optimized for Pediatric Patients With Renal Impairment Using Physiologically Based Pharmacokinetic ModelingJie Zhou, Xiang You, Guimu Guo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 26, 2024
Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of Ustekinumab in pediatric patients with inflammatory bowel diseaseXiaoxi Cai, Wanhong Wu, Guimu Guo, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Expert Opinion on Drug Safety|January 21, 2026
Dipyridamole-associated pulmonary edema: discovery of a new potential adverse reaction signal based on the FAERS databaseXiaomin Dong, Guimu Guo, Jintuo Zhou, et al.
Journal of Pharmaceutical Sciences|October 27, 2021
Development of Physiologically Based Pharmacokinetic Model for Pregabalin to Predict the Pharmacokinetics in Pediatric Patients with Renal Impairment and Adjust Dosage Regimens: PBPK Model of Pregabalin in Pediatric Patients with Renal ImpairmentChengjie Ke, Xiang You, Cuihong Lin, et al.
Journal of Endocrinological Investigation|May 6, 2026
Mining safety signals of PD-1/PD-L1 inhibitor-related adrenal insufficiency: a study based on the FAERS databaseRuoxuan Pan, Tingting Chen, Guimu Guo, et al.
Clinical Pharmacology and Therapeutics|August 24, 2023
Physiologically-Based Pharmacokinetic Modeling of Anti-Tumor Necrosis Factor Agents for Inflammatory Bowel Disease Patients to Predict the Withdrawal Time in Pregnancy and Vaccine Time in InfantsJiarui Chen, Rongfang Lin, Guimu Guo, et al.
Pharmaceutics|November 11, 2022
Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to OxcarbazepineLixia He, Meng Ke, Wanhong Wu, et al.
Journal of Pharmaceutical Sciences|November 3, 2025
Pharmacokinetic prediction and dosage adjustment of enoxaparin administration in pregnant women with renal insufficiency: A FAERS-PBPK modeling studyGuimu Guo, Lingling Ye, Tingting Chen, et al.
Frontiers in Pharmacology|April 15, 2025
Physiologically based pharmacokinetic model of sodium-glucose cotransporter 2 inhibitors predicted pharmacokinetics and pharmacodynamics to explore dosage regimen for patients with type 2 diabetes mellitus and renal insufficiencyGuimu Guo, Meng Ke, Jianwen Xu, et al.
Journal of Clinical Pharmacology|July 30, 2021
Ceftaroline Dosage Optimized for Pediatric Patients With Renal Impairment Using Physiologically Based Pharmacokinetic ModelingJie Zhou, Xiang You, Guimu Guo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 26, 2024
Physiologically-based pharmacokinetic modeling to predict the exposure and provide dosage regimens of Ustekinumab in pediatric patients with inflammatory bowel diseaseXiaoxi Cai, Wanhong Wu, Guimu Guo, et al.
Pageof 2